APA (7th ed.) Citation

Luo, T., Peng, D., Zhang, Z., Yang, M., Guo, X., Ma, T., . . . Zhang, Y. (2026). Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker. Annals of Clinical & Translational Neurology, 13(4), 796. https://doi.org/10.1002/acn3.70261

Chicago Style (17th ed.) Citation

Luo, Tiancheng, et al. "Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker." Annals of Clinical & Translational Neurology 13, no. 4 (2026): 796. https://doi.org/10.1002/acn3.70261.

MLA (9th ed.) Citation

Luo, Tiancheng, et al. "Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker." Annals of Clinical & Translational Neurology, vol. 13, no. 4, 2026, p. 796, https://doi.org/10.1002/acn3.70261.